ArticleJournal of hematology & oncology2024

The small inhibitor WM-1119 effectively targets KAT6A-rearranged AML, but not KMT2A-rearranged AML, despite shared KAT6 genetic dependency.

Mathew Sheridan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.